Patient-derived xenografts (PDXs) of human gliomas in murine models are unmatched in representing the molecular heterogeneity of the disease, but typically do not present with MRI contrast, and thus are not phenotypical. This may pose a limit to the assessment of trial therapies. PDX preparations were tweaked by co-injecting Matrigel with neurospheres. In one of the two cell lines studied, Matrigel promoted the formation of brain tumors whose genetic composition was that of the original human GBMs and whose radiologic appearance on MRI was similar to that seen in humans. In the second cell line, no BBB breakdown occurred.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords